Thursday, 15 December 2016

Integration of IoT and Nanotechnology will Drive Demand for and Sales of Anti-snoring Devices and Snoring Surgery, TMR says

The presence of an increasing number of companies manufacturing and selling anti-snoring devices today has rendered the competitive landscape of the anti-snoring devices and snoring surgery market extremely fragmented, Transparency Market Research (TMR) finds. GE Healthcare, Philips Healthcare, Fisher & Paykel Healthcare, Medtronic plc, and ResMed, Inc. are not only the prominent players in the global anti-snoring devices and snoring surgery market but also account for a significant percentage share of the overall market. Although SomnoMed does not account for a major share in terms of percentage, its extensive product portfolio and robust market presence makes it a strong contender in the anti-snoring devices and snoring surgery market.
A slew of recent acquisitions have enabled Medtronic to emerge as the largest revenue contributor when it comes to anti-snoring devices. The top three companies in the global anti-snoring devices and snoring surgery market – namely Medtronic, GE Healthcare and Philips Healthcare, contribute a whopping 93.69% to the entire revenue pie. TMR has observed that a surge in R&D activities has strengthened the position of these companies in the global anti-snoring devices and snoring surgery market.
TMR makes several key projections on the future outlook of this market.
Demand for low-cost and connected devices will gain speed
“The introduction of innovative devices is just as vital in gaining a competitive edge,” says a TMR analyst. “Anti-snoring device companies have been increasingly focused on improving the performance of existing products. The miniaturization of sleep apnea devices is a recent trend driven by the integration of nanotechnology.
The demand for compact and low-cost devices has provided vendors a major opportunity. Case in point, Airing LLC. The medical device company launched a revolutionary disposable, battery-operated, and cordless micro-continuous positive airway pressure (CPAP) device in May 2015.
The large-scale proliferation of the Internet of Things (IoT) has penetrated the medical devices sector as well. The growing demand for connected and wireless devices as well as remote patient monitoring is reflected in the way an increasing number of anti-snoring devices companies are integrating IoT with their products. Medco Health is one such company. In February 2015, the medical device maker launched an innovative telemedicine assistance system that not only monitors the sleeping patterns of patients with obstructive sleep apnea disorder but also helps schedule doctors’ appointments.
It has been observed that leading vendors have also been investing significant resources in enhancing the performance of anti-snoring devices to drive the acceptance and sales of anti-snoring devices.
Companies will need to overcome lack of patient compliance to spur sales
The demand for anti-snoring devices and snoring surgery is being driven by a number of physiological factors. A surge in the incidence of obstructive sleep apnea, an increase in the number of people suffering from sleep deprivation and snoring, and an alarming prevalence of obesity have considerably fueled the need for anti-snoring devices. “People with obesity are four times more likely to snore compared to those of normal weight,” states TMR based on its findings.
The development of state-of-the-art technologies by market players and a focus on extensive marketing have also enhanced the uptake of anti-snoring devices.
In contrast, a lack of patient compliance, certain side effects such as throat dryness and nasal congestion, ambiguity in handling the device have limited the use of anti-snoring devices among patients. The high price of these devices is also a major factor dampening the sales of the devices.
Competitive pricing of devices is likely to curb high revenue growth
The global market for anti-snoring devices and snoring surgery is projected to expand at a steady 3.9% CAGR from 2016 to 2024, with the market opportunity rising from US$16 bn in 2015 to US$22.7 bn by 2024. Continuous positive airway pressure (CPAP) devices rake in the highest revenue in terms of device. The opportunity of this device segment is forecast to increase from US$12.1 bn in 2015 to US$16.4 bn by 2024.
On the other hand, tongue stabilizing devices (TSDs) are likely to witness the highest growth, with sales rising from 32.81 mn units in 2015 to 51.54 mn units by the end of 2024. However, TMR states that the competitive pricing of these devices limits revenue growth.
The information presented in this review is based on the findings of a report by Transparency Market Research titled “Anti-snoring Devices and Snoring Surgery Market - Global Industry Analysis, Size, Growth, Trends, and Forecast 2015 - 2023.”

With Recent Shift from Invasive to Non-Invasive Technology, Intracranial Pressure Monitors Likely to Witness Mounting Demand

Upswing in Brain injuries Demands Increased Application of Intracranial Pressure Monitors
The increased prevalence of traumatic injuries and strokes has laid the ground for the immense rise of the global intracranial pressure monitors market. The upswing in the cases of brain injuries in children as well as adults has also boosted the demand for intracranial pressure monitoring remarkably across the world. However, the biggest influence on this market, which stood at US$0.94 bn in 2014, has been accredited to the substantial shift from invasive pressure monitors to non-invasive pressure monitors. This trend is expected to have an enduring effect on the dynamics of demand and supply of these monitors.
Transparency Market Research expects this market to rise at a CAGR of 6.30% between 2015 and 2023, with business opportunity reaching US$1.63 bn by the end of 2023. Untapped developing countries are anticipated to present opportunity-rich market for participants in the global market for intracranial pressure monitors.
A significant growth can be witnessed in the demand for intracranial pressure monitors with their increasing application in the detection and management of various cerebrovascular disorders such as meningitis, traumatic brain injury, brain tumor, and intracerebral hemorrhage.
In 2013, the traumatic brain injury segment accounted for the biggest share in the demand for intracranial pressure monitors. TMR projects this segment to rise at a rapid CAGR of 7.70% between 2015 and 2023. The increase in violence, rising industrial as well as road accidents, and rising number of reports related to head injuries due to sports and recreational activities are the prime reasons behind the growing prevalence of traumatic brain injuries.
Growing Prevalence of Traumatic Injuries Fuels Demand for Intracranial Pressure Monitors in North America
The market for intracranial pressure monitors stretches across North America, Europe, Asia Pacific, and the Rest of the World. North America has surfaced as the biggest contributor to the intracranial monitor consumption since the past few years. The increasing prevalence of neurological disorders and traumatic injuries have amplified the application of these monitors in this region. Additionally, technical advancements in the field of pressure monitoring are expected to influence the sales volume of these monitors considerably in North America over the coming years.
Although North America will remain the leading regional market for intracranial pressure monitors during the forecast period, Asia Pacific will offer the most profitable opportunities to market players, on account of the presence of a large number of untapped markets.
Apart from this, the augmenting incidence of cerebrovascular disorders, fuelled by the increasing base of geriatric population, and the rising expenditure on healthcare, owing to surging disposable income, are also projected to boost the demand for these monitors in the near future. Europe holds the second position in the worldwide intracranial pressure monitors market.
Integra LifeSciences Corp., Medtronic Inc., and Codman & Shurtleff Inc. are leading the global intracranial pressure monitors market. The collective share of these three companies in the overall market is 53.4%. Other prominent manufacturers of intracranial pressure monitors are Haiying Medical, HeadSense Medical Inc., Raumedic AG, Spiegelberg GmbH & Co. KG., and SOPHYSA.

Cardiac Rehabilitation Market - Latest Trends & Insights 2024

In the highly consolidated global market for cardiac rehabilitation, innovations and product costs will be major determinants of success, marks a recent report by Transparency Market Research. The top two companies in the market, Brunswick Corporation and Technogym, had a clear hold on the market’s overall growth prospects, accounting for a combined share of over 50% in 2015. Other leading vendors such as Brunswick Corporation, Johnson health Tech Co., and Amer Sports, in combination with these two companies, accounted for a share of nearly 70% in the global market in the same year.
Characterized by high competitive rivalry, high rate of introduction of technologically advanced products, and a continuous rise in global demand, the market for cardiac rehabilitation will emerge as a lucrative investment hub for investors in the years to come.
Rising Global Population of Geriatrics to be Major Driver
The world’s population of people aged more than 60 years is rising at a rapid pace, upping the risk of cardiovascular diseases as aging has a major impact on the body’s cardiovascular system. This factor is also the root cause of the increasing rates of morbidity, disability, mortality, and a substantial rise in the world’s healthcare costs. According to the Institute for Health Metrics and Evaluation, the world’s geriatric population suffered a 55% rise in deaths due to cardiovascular diseases between the period of 1990 and 2013.
WHO statistics, on the other hand, highlight another major concern – the high prevalence of cardiovascular diseases and resultant rise in deaths in developing and underdeveloped countries. Low- and middle-income countries in developing and underdeveloped parts of the globe account for a staggering 82% share in the total number of deaths caused due to non-communicable diseases across the world; of these, cardiovascular diseases account for a massive 37% share. Driven with the aim of improving the situation, sustained efforts for preventing and treating cardiovascular diseases undertaken on national and international levels will have a major impact the global cardiac rehabilitation market in the future.
High Product Costs to Constrain Demand for Cardiac Rehabilitation
Being a highly capital- and research-intensive marketplace, cardiac rehabilitation products, quite naturally, carry a high price tag and always carry the risk of being outclassed by newer and most often technologically advanced products in the market. In this highly dynamic market, where the rate of introduction of technologically advanced varieties of product types is immense, the high and rising costs of cardiac rehabilitation products are a major restraints for further expansion. Cost is a major constraint especially for the market’s growth in developing regions such as Asia Pacific and Latin America.
Apart from the factor of cost, low enrolments in cardiac rehabilitation programs and lack of skilled resources providing cardiac rehabilitation services are also major restraints for the global cardiac rehabilitation market. To overcome the challenge of low enrolments, vendors will have to focus more on formulating programs that have flexible schedules and are sensitively priced according to the region of operation. Intervention from government and private educational institutes will be necessary for increasing the number of rehabilitation counsellors on a global front.
The global market for cardiac rehabilitation had a valuation of US$1,010.93 mn in 2015. It will expand at a healthy 5.4% CAGR from 2016 through 2024 and rise to a valuation of US$1,622.9 mn by 2024.
This analysis of the global cardiac rehabilitation market has been based on a recent market research report, titled “Cardiac Rehabilitation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

Patient Handling Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Transparency Market Research has published a new market report titled, “Patient Handling Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024” According to the report, the global patient handling equipment market was valued at US$ 9.5 Bn in 2015 and is anticipated to expand at a CAGR of 10.2% from 2016 to 2024 to reach US$ 22.4 Bn in 2024.
The patient handling equipment market is witnessing various new opportunities such as rental provisions emerging as a market trend among patients who require slings and lifts for short duration (i.e. for four months to six months) in healthcare settings. Moreover, provision for flexible rental payments enables rental providers in effectively managing cash flow throughout the year. These factors would further propel the growth of this market. The major drivers for the market growth include need for prevention of musculoskeletal injuries to both care providers as well as patients due to manual lifting of patients. In such cases, these equipment are considered the right option to lift patients in a proper manner. Secondly, the cost savings on labor will be directed to purchase equipment such as patient lifts, medical beds with assistive technology, and other such equipment, eventually minimizing the role of caregivers in assisting patients. The high benefit to cost ratio for investment made by health care settings will incentivize their adoption rates for patient handling equipment in developed economies.
The research report analyzes the current and future prospects of the patient handling equipment market across the globe during the forecast period from 2016 to 2024. Based on product type, the patient handling equipment market has been categorized into lifting slings, wheelchairs, medical beds, ambulatory aids, shower, bath and toileting equipment, and others comprising patient lifts, transfer assists, lateral and repositioning devices, patient turners, leg lifters, and transfer poles. The report provides market size in terms of US$ Mn, volume (No. of Units), and compound annual growth rate (CAGR %) for each product segment during the forecast period from 2016 to 2024, considering 2014 and 2015 as base years. The report also analyses the patient handling equipment market from an end users perspective, for segments such as Hospital, Nursing Home, Assisted Living Facility, Home Healthcare, and Others (Trauma, paramedical and rehabilitation centers).
Medical bed segment accounted for the largest market share of the global patient handling equipment market in 2015. Considering that medical beds are a mandatory capital investment, for clinical settings, the product segment is expected to witness consistent demand from end users. In addition, an increasing number of high-end super-specialty hospitals are willing to make substantial capital investment for technologically advanced and ergonomically designed medical beds considering the long-term advantages. Patient care often necessitates lifting or providing body movements to perform daily activities such as walking, toileting, and bathing. Such tasks involve handling of patients with proper care. Patient handling equipment are devices used in hospitals and nursing homes to transfer patients with restricted mobility.
Low awareness and apprehensions on return to investment by end-users for expensive technologically advanced equipment are likely to hamper the growth of the market. Developing countries such as India, Sri Lanka etc. are devoid of legal and regulatory protocols pertaining to patient handling for patients as well as caregivers. As a result, the health care system in these regions is fragmented, with presence of small and medium scale end-users devoid of foresighted benefits of patient handling equipment. However, due to political pressures from international bodies aiming to improve health care services across the globe, various countries will be rolling out new policies for developing a patient centered health care system. These government initiatives for improving the quality of patient care and decent work culture for caregivers employed in health care settings is likely to augment the market, especially in Asia Pacific.
The major companies operating in the global patient handling equipment market are ArjoHuntleigh (Getinge Group), DJO Global, V.Guldmann A/S, Hill-Rom Holdings, Inc., Etac AB, Invacare Corporation, Joerns Healthcare LLC, Patterson Medical Holdings, Inc., Permobil AB, Prism Medical, Stiegelmeyer & Co. GMBH, and Stryker Corporation, Sunrise Medical LLC. ArjoHuntleigh (Getinge Group) was identified as the leading player in the global patient handling equipment market in 2015.

Wednesday, 14 December 2016

Surgical Procedures Volume Market: Industry Players Shifting Focus towards Developing Economies

Rising geriatric population across the world has been identified as a major factor fueling the growth of the surgical procedures market. This is primarily due to elderly people are highly susceptible to various chronic disorders. Moreover, growth in the global population over 65 years of age would highly affect market growth. According to the U.S. Census Board, people older than 65 years represented around 13% of the total population; this percentage is expected to reach 20% by 2030. According to the World Health Organization, the global geriatric population is anticipated to reach 1.5 billion by 2050. Countries aging at a rapid pace are the U.S., Japan, and Germany. Other factors driving the surgical procedures volume globally include increasing incidence of chronic disorders and rise in the number of trauma injury cases. The surgical procedures volume market has been segmented into cardiovascular, orthopedic, neurosurgery, ophthalmic, gynecology, and other procedures such as urology and dental.
The cardiovascular procedures segment has been further categorized into cardiac rhythm management devices implantations, interventional cardiology procedures, and heart transplantation. The interventional cardiology procedures sub-segment held the largest share of the cardiovascular procedures segment due to rising usage of cardiac catheterization in structural heart disease and is becoming complex due to increase in incidence of therapeutic catheterization. According to the American Heart Association, over 5 million people in the U.S. are diagnosed with heart valve disease each year, thereby making coronary angiography the leading segment in the interventional cardiology procedures market. The neurosurgery procedures segment has been sub-segmented into craniotomy, aneurysm coil embolization, CSF drainage, and CSF shunts. CSF drainage was the largest sub-segment of the neurosurgery segment, while the craniotomy sub-segment is anticipated to grow at the fastest rate during the forecast period due to recent developments in intraoperative imaging technologies. Orthopedic procedures have been categorized into three segments: joint replacement surgery, ligament/tendon repair surgery, and spine surgery. Joint replacement was the largest sub-segment of the orthopedic procedures segment. The sub-segment is further segmented into knee replacement, hip replacement, and shoulder replacement surgery. Knee replacement surgery dominated the joint replacement surgery segment as it is considered the most effective intervention for severe osteoarthritis, reducing pain and disability, and restoring patients to near normal function. The ophthalmic procedures segment has been categorized into three sub-segments: cataract surgery, refractive surgery, and glaucoma surgery. The cataract surgery sub-segment held the largest share of the global ophthalmic procedures market and in expected to expand at the highest CAGR due to technological advances and better efficacy of the procedures. Gynecology procedures have been categorized into three segments: hysterectomy surgery, uterine artery embolization, and cesarean section surgery. The continued growth of the global gynecology procedures market is attributed to changing lifestyle, increase in per capita income in the emerging markets, and rising prevalence of gynecological diseases such as menorrhagia, uterine fibroids, and cervical cancers globally. The other procedures segment includes urology procedures and dental procedures. The dental procedures sub-segment is anticipated to witness highest growth rate during the forecast period due to technical advancements leading to higher productivity and efficacy.
Asia Pacific dominated the global surgical procedures market in 2014, accounting for a share of over 30% primarily due to large patient base, increasing incidence of cardiovascular diseases, traumatic injuries, neurological disorders, and introduction of advanced surgical technologies. Increase in the geriatric population also plays a major role in the growth of the surgical procedures market. Population over 65 years of age in Asia is likely to increase dramatically by 314%, from 207 million in 2000 to 857 million in 2050. This will increase the number of surgery procedures in the region. North America was the fastest growing market for surgical procedures in terms of volume during the forecast period from 2014 to 2023, due to growing innovation and adoption of new surgical technologies, high growth of minimally invasive surgeries, and C-section surgeries. Moreover, efficient reimbursement facilities, large health care infrastructure, rise in the health care expenditure, and high number of hospital beds per capita are anticipated to accelerate the medical infrastructure development in the U.S. making it the dominating segment in North America. Europe was the second largest market for surgical procedures in terms of volume in 2014, accounting for a share of 31.1% of the global market. Primary factors driving growth in the region include increase in the geriatric population and rise in the incidence of fall injuries, traffic-related injuries, cardiovascular diseases, and orthopedic cases. According to the European Commission database, the average number of surgical procedures for cardiac disorders has increased by around 20% from 2005 to 2010. Germany held the largest share of the surgical procedures market in Europe in 2014 due to the better reimbursement mechanism. Brazil accounted for the largest share of the surgery procedures market in Latin America. Growth of the market is attributed to high prevalence of chronic diseases, rise in geriatric population, and increase in health care expenditure. Mexico is expected to be the fastest growing market in Latin America due to low cost of medical treatments and high prevalence of chronic and infectious diseases.

Temperature Probe Market Grows with Increased Adoption Rate of Surveillance and Checkup Devices

Temperature probes are used to measure the amount of coldness and heat energy, generated by a system. These sensors help in detecting physical change to the temperature producing digital output. Furthermore, temperature sensors are mainly used in sectors including healthcare, food & beverage, automotive and consumer electronics, defense industry. They have proved to be essential in serving the growing demand for advance automation in the
Temperature sensors are used in various industrial applications, which need process control with high accuracy. These probes are mainly used for sensitive processes, which need controlled process environments for example in chemical mixing, monitoring. Industrial processes which frequently requires to test and measure equipment’s temperature and volume, also use temperature probes on large scale. For example, clinical research processes have highly controlled manufacturing environments.
These probes play important role in manufacturing, handling, storing of medical equipment and drugs, as they maintain basic overall performance by monitoring temperature. The current developments in healthcare sensing probes are responsible for increase in the trend of continuous patient monitoring. As a result it can reduce overall healthcare costs and help to improve treatment outcomes. These medical sensors are capable of monitoring of vital signs, for example patients temperature and blood pressure that are directly recorded in the electronic format. It also reduces sloppy management of patient records and providing the user with the latest information. Currently consumer healthcare is amongst the major fields which holds a promising future for sensors with a fastest growth rate than all other applications.
The escalating burden of chronic disorders as well as, the worldwide, surging population count has consequently propelled the demand for these equipment’s. Chronically ill patients and the large elderly population subset form the target population for the sensor-based devices as it is imperative for them to undergo routine checkups; thus, facilitating remote and point-of-care patient monitoring.
Besides this, increased adoption rate of surveillance and checkup devices are further driving the temperature sensors market. In addition, factors such as strict government guidelines to ensure environmental safety and ongoing demand for electronic products and computing peripherals have kept the prospects of the market high.
The raw material used for manufacturing plays a crucial role in sensor efficiency and durability. Use of new raw materials such as lithium-niobate and langasite has increased the measurement ranges of temperature sensors. However, silicon based sensors are primarily used owing to their availability and low cost as they are produced in bulk. Multisensors are increasingly used for mass applications owing to their stability which, is expected to drive overall temperature sensors market growth.
Technical developments and advent of Micro-Electro-Mechanical Systems (MEMS) are likely to create greater opportunities.
The home healthcare category such as pregnancy kits and glucose monitoring kits is anticipated to witness lucrative growth over the years. The cost of diagnosis in hospitals and other healthcare units is high; hence, the preference of home healthcare equipment’s, such as diagnostic kits, over hospitals is observed to be rising. The high-unmet needs of the huge target population are expected to further open avenues for the market players in the industry.
However, dominance of legacy technologies and awareness of end-users have hampered the market growth. Quality, accuracy of temperature probes and raw material used for manufacturing has hampered the market.
The Global Market of Temperature Probe is segmented on basis of product type, application, end user, and geography. The market by product type includes fiber optic, temperature sensors IC, bimetallic, resistance temperature detector, IR temperature sensor, thermistor, and thermocouple. Based on applications, the market is segmented as surgical, diagnostic, therapeutic and monitoring. The end user of temperature probes include hospitals, physician offices, nursing homes, home healthcare facilities and others.
Geographically, the market is segmented into six major regions: North America, Europe, Asia-Pacific, Latin America, Middle East and Rest of the World (RoW). In terms of geography, North America followed by Europe account for the largest market share for because of availability of sophisticated primary, secondary, and tertiary-care healthcare settings supported the market. Moreover, the well-established reimbursement network, suitable government funding, and the increasing health awareness further facilitates the incorporation of the sensors in the medical devices.
The Asia Pacific region is anticipated to witness a remunerative growth over the next few years. This can be attributed to the heightened number of individuals suffering from chronic disorders, such as diabetes, hypertension, and respiratory problems.
The key market players active in the temperature sensor market are Analog Devices Inc., Maxim Integrated, Measurement Specialties Inc., Microchip Technology Inc., Honeywell International Inc., NXP Semiconductors, STMicroelectronics, Panasonic Corporation, Texas Instruments and Siemens AG.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Endometrial Ablation Market - Needs to treat abnormal uterine bleeding

Endometrial ablation is a procedure to surgically destroy the endometrial layers or uterine lining without removing reproductive organ. Heavy menstrual bleeding may arise due to hormonal imbalance, uterine fibroids and polyps, infections of the uterus and cervix, bleeding disorders, and uterine cancer. Endometrial ablation is non-hormonal, minimally invasive procedure alternative to hysterectomy for abnormal uterine bleeding such as menorrhagia. It is used when the heavy bleeding is not controlled by medications and/or hormonal treatments. This is an outpatient procedure and offers low complications and high efficacy rates as compared to other surgical procedures. It is mostly performed among the women who would not wish to have children in future as it may reduce the chances of getting pregnant. This is because the lining that helps fetus to grow are removed during the procedure. Therefore this procedure cannot be performed in pregnancy.
Endometrial ablation is an emerging method and mostly preferred over other surgical procedures among women with abnormal uterine bleeding. Moreover, it is observed that women with high risk of heavy menstrual bleeding opts for endometrial ablation to ensure quality and safety treatment option. Endometrial ablation has been shown to be less costly in both the short term and at five years treatment plan as compared to hysterectomy (abdominal, laparoscopic and vaginal). . Due to short turnaround time and speedy recovery endometrial ablation is preferred by many physicians worldwide. Endometrial ablation can be performed under local anesthetic and takes only few minutes to perform thye surgery and thereby reduces the patient’s stress and discomfort. Although, this is considered as a preferable procedure over hysterectomy, dilatation and curettage, however it also possesses certain risk factors such as perforation of the uterus (accidental puncture), thermal injury to uterus, cervical laceration. It is observed that the above mentioned problems are persists among less number of patient however proper treatment and guidance may overcome the situation. Younger women with heavy bleeding may not opt for endometrial ablation as there are high chances of recurrence in younger women.
A variety of endometrial ablation techniques and devices have been evaluated and used to perform surgery. The procedures initially developed are usually referred to as first-generation devices. In recent times it is observed that second generation devices such as thermal balloon ablation and bipolar ablation are more popular among people. The Endometrial ablation market has been segmented by device type, technology, and geography. By device type, market can be segmented as first generation, balloon ablation and bipolar ablation devices. Based on technology the market has been segmented into, microwave technology, cryotherapy technology, radiofrequency technology, thermal technology, ultrasound technology, hydromechanical technology, electrical technology, light technology, and radiation technology. The global endometrial ablation market is driven by the aging population, as heavy menstrual bleeding is majorly observed among geriatric females. Technological advancement towards minimally invasive surgical devices would also derive the global market demand for endometrial ablation market.
Geographically the market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America contributed the largest share of endometrial ablation market due to increasing healthcare awareness and technological advancement in the region. Followed by Europe contributed the second largest share to endometrial ablation market growth with aging European population. However, Asia Pacific region is expected to be the fastest growing market due to the gradual adoption of improved, next-generation technologies, emerging health care infrastructures, and raising population susceptible to various diseases/conditions.
The key players operating in the endometrial ablation market includes Hologic, Inc., Olympus Corporation, Ethicon US, LLC., Bioteque America Inc., KARL STORZ GmbH & Co. KG, Boston Scientific Corporation, Smith & Nephew plc., CooperSurgical Inc., and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.